Home Nanomics

Nanomics

In operation
Series PreA
Developer of AI Proteomics High-Throughput Automation Technology Platform
Basic
Enterprise Profile
LinkedIn

Basic Information

Nanomics is committed to the independent development of a high-throughput automation technology platform for the AI proteomics industry, integrating experimentation and computation, and combining nanotechnology, microfluidics, automation, mass spectrometry, and artificial intelligence to empower applications such as biomarker discovery, protein-protein interactions, drug discovery, optimization of nanocarriers for delivery, and liquid biopsy.
Nanomics Biotech
Zhejiang,China
unclear
April 22, 2021
lipingwu@nanomics.bio

Enterprise Profile

Industrial Sector
New Drug Development Medical Device R&D and Design Information Technology Vendors Big Data and Cloud Computing Services # Diagnostic Manufacturing CRO
Technology
Liquid Biopsy Molecular Diagnostics Microfluidics Artificial Intelligence Biotechnology
Concept
Disease Diagnosis
Application Scenarios
Innovative Drugs Big Data AI+Pharmaceuticals Nanotechnology Medical Device Consumables Early Disease Screening